Review



pbs per mouse  (Bio X Cell)


Bioz Verified Symbol Bio X Cell is a verified supplier
Bioz Manufacturer Symbol Bio X Cell manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    Bio X Cell pbs per mouse
    Pbs Per Mouse, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 97/100, based on 1148 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd8+antibody+in+pbs/Anti-CD8+Cd8A+Antibody/pmc10847518-470-22-27
    Average 97 stars, based on 1148 article reviews
    pbs per mouse - by Bioz Stars, 2026-11
    97/100 stars

    Images

    Related Articles

    Injection:

    Article Title: CD8 + T-cell Immune Evasion Enables Oncolytic Virus Immunotherapy
    Article Snippet: .. To deplete CD8 + T-cells, 100 μg anti-CD8 + antibody in PBS ( anti-mouse CD8a clone 2.43 , BioXCell , cat. #BE0061) was injected into each mouse (once daily beginning 3 days prior to commencing OV treatment, and every 6 days thereafter). ..



    Similar Products

    90
    Becton Dickinson anti-cd8-pb
    Expression and functional characterization of CARs using different S-binders. (A) Schematic representation of CAR constructs. (B) Exemplary flow cytometry plots of retroviral transduction of primary human <t>CD8</t> + T cells with C8-, 4D06-, and 4D08-CARs. (C) Transduction rates of CD4 + and CD8 + T cells from two healthy donors for C8-, 4D06-, and 4D08-CARs determined by flow cytometry. (D) Expression levels of C8-, 4D06-, and 4D08-CARs shown as mean fluorescence intensity (MFI) of CAR+ population (does not apply to mock cells). (E) 1x10 5 CAR-transduced T cells were cultured on plate-bound HBsAg titrated from 0.01-10 µg/ml. IFNγ secretion was measured after 48h by ELISA. Data points represent mean values ± SD from triplicates.
    Anti Cd8 Pb, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd8+antibody+in+pbs/cd8+pb+antibody/pmc11072186-129-5-6
    Average 90 stars, based on 1 article reviews
    anti-cd8-pb - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    97
    Bio X Cell pbs per mouse
    Expression and functional characterization of CARs using different S-binders. (A) Schematic representation of CAR constructs. (B) Exemplary flow cytometry plots of retroviral transduction of primary human <t>CD8</t> + T cells with C8-, 4D06-, and 4D08-CARs. (C) Transduction rates of CD4 + and CD8 + T cells from two healthy donors for C8-, 4D06-, and 4D08-CARs determined by flow cytometry. (D) Expression levels of C8-, 4D06-, and 4D08-CARs shown as mean fluorescence intensity (MFI) of CAR+ population (does not apply to mock cells). (E) 1x10 5 CAR-transduced T cells were cultured on plate-bound HBsAg titrated from 0.01-10 µg/ml. IFNγ secretion was measured after 48h by ELISA. Data points represent mean values ± SD from triplicates.
    Pbs Per Mouse, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd8+antibody+in+pbs/Anti-CD8+Cd8A+Antibody/pmc10847518-470-22-27
    Average 97 stars, based on 1 article reviews
    pbs per mouse - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    90
    Becton Dickinson anti cd8-pb
    Sorted naive p14 <t>CD8</t> T cells were transferred into CD45.1 recipient mice one day prior to intravenous infection with 2 × 10 6 PFU LCMV Cl13. Mice were euthanized at various time points after infection. Graphs show (A) representative flow cytometry plots (left) and the frequency (right) of p14 CD8 T cells present in the spleen of infected mice; (B) the percentage of KLRG1 + CD127 - p14 CD8 T cells expressing IRF-5; (C) the percentage of CD44 + CD127 + p14 CD8 T cells expressing IRF-5; and (D) the frequency of IRF-5 expression that colocalizes with DAPI staining over the course of LCMV Cl13 infection. Data represent the mean ± SEM of one of 2 or 3 independent experiments, n = 4-5.
    Anti Cd8 Pb, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd8+antibody+in+pbs/cd8+pb+antibody/bio_rxiv__2024__01__29__577789-237-16-22
    Average 90 stars, based on 1 article reviews
    anti cd8-pb - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Becton Dickinson pb-conjugated anti-cd8 t cell antibody
    Vaccination of C57Bl/6 mice with rMVA-HBc±CD70. ( A ) C57Bl/6 mice were immunized subcutaneously with HBcAg adjuvanted with CpG and PCEP at day 0 (group wt received adjuvants only). At day 21, mice were boosted with MVAwt (group wt), rMVA-HBc (group HBc) or rMVA-HBc-CD70 (group HBc-CD70) by intraperitoneal injection. At day 35, splenocytes of mice were isolated and stained with PE-labelled C 93 multimers to determine the amount of HBc-specific <t>CD8</t> <t>T</t> cells ( B ) showing representative dot plots and ( C ) showing the group analysis. The table ( C ) shows the proportion of all CD8+ T cells. At day 35, splenocytes of vaccinated mice were also stimulated ex vivo with C 93 or B8R peptides for intracellular cytokine staining (ICS) to evaluate C 93 - or B8R- specific IFNγ-, TNFα- and IL2 production of CD8 T cells ( D ) showing representative dot plots and ( E ) showing the group analysis. ( F ) Simultaneous detection of IFNγ, TNFα and IL2 production of CD8 cells upon HBc stimulation ex vivo: dot plots show one representative mouse of each group. The table shows the mean values (% of CD8+ cells) of 4 mice/group. ( G ) The gain of function of CD8 T cells after CD70 co-stimulation during vaccination: the proportion of IFNγ+ CD8 T cells upon ex vivo C 93 stimulation was set in relation to the proportion of C 93 multimer-positive CD8 T cells in the same animals. Proportions were calculated for each mouse separately. C 93 : HBcAg CD8 T cell epitope; B8R: MVA-derived CD8 T cell epitope. Crosses and triangles represent individual mice; horizontal lines indicate mean values; error bars indicate standard deviation. Statistics: one-way ANOVA and subsequent unpaired t-test, n.s.: not statistically significant.
    Pb Conjugated Anti Cd8 T Cell Antibody, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd8+antibody+in+pbs/anti+cd8+abs/pmc09966001-73-5-12
    Average 90 stars, based on 1 article reviews
    pb-conjugated anti-cd8 t cell antibody - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Becton Dickinson anti-cd8 pacific blue (pb
    Interleukin (IL)-7 promotes expansion of splenic T and B cells . Total number of thymocytes was not affected by IL-7. The absolute numbers of CD4CD8 double negative (DN), CD4CD8 double positive (DP), and single-positive CD4 and <t>CD8</t> thymocytes were not changed by treatment with IL-7 (A) . Peripheral cell numbers, measured by total numbers of splenocytes, CD4 + T cells, CD8 + T cells, CD19 + B cells, and germinal center (GL7 + ) B cells were all increased by IL-7 compared with PBS treatment (B) . Values are expressed as mean ± SEM of 15 mice per group. Statistical differences with PBS group of * P < 0.05 or ** P < 0.005.
    Anti Cd8 Pacific Blue (Pb, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd8+antibody+in+pbs/anti+cd3/pmc03446520-61-12-17
    Average 90 stars, based on 1 article reviews
    anti-cd8 pacific blue (pb - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    86
    Thermo Fisher anti cd8 pacific blue pb
    Interleukin (IL)-7 promotes expansion of splenic T and B cells . Total number of thymocytes was not affected by IL-7. The absolute numbers of CD4CD8 double negative (DN), CD4CD8 double positive (DP), and single-positive CD4 and <t>CD8</t> thymocytes were not changed by treatment with IL-7 (A) . Peripheral cell numbers, measured by total numbers of splenocytes, CD4 + T cells, CD8 + T cells, CD19 + B cells, and germinal center (GL7 + ) B cells were all increased by IL-7 compared with PBS treatment (B) . Values are expressed as mean ± SEM of 15 mice per group. Statistical differences with PBS group of * P < 0.05 or ** P < 0.005.
    Anti Cd8 Pacific Blue Pb, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd8+antibody+in+pbs/pmc04745915-203-24-28
    Average 86 stars, based on 1 article reviews
    anti cd8 pacific blue pb - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    90
    Thermo Fisher anti-cd8-pb
    A) C57BL/6 mice were randomized to control vs. cancer groups. The cancer group received a subcutaneous injection of Pan02 cells. Following 3 weeks, all mice were given an IV injection of transgenic (Tg) T cell receptor (TCR) <t>CD8</t> + Thy1.1 + T cells. After 24 hours, uninfected mice were sacrificed for the day 0 time point, and all other mice were given an intraperitoneal injection of LM-OVA and underwent spleen collections at days 5 and 14 post-infection. B) At days 5 or 14 following infection, there were no significant differences in antigen-specific CD8+T cells expansion between the control and cancer groups. The mean frequencies in control vs. cancer were 6.97±1.49% vs. 6.89±2.49% at day 5, respectively and 5.38±0.73% vs. 4.90±1.19% at day 14, respectively; n = 8–10 at all time points.
    Anti Cd8 Pb, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd8+antibody+in+pbs/pmc04010417-44-13-20
    Average 90 stars, based on 1 article reviews
    anti-cd8-pb - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    94
    Bio X Cell pbs bioxcell invivomab anti mouse cd8
    A) C57BL/6 mice were randomized to control vs. cancer groups. The cancer group received a subcutaneous injection of Pan02 cells. Following 3 weeks, all mice were given an IV injection of transgenic (Tg) T cell receptor (TCR) <t>CD8</t> + Thy1.1 + T cells. After 24 hours, uninfected mice were sacrificed for the day 0 time point, and all other mice were given an intraperitoneal injection of LM-OVA and underwent spleen collections at days 5 and 14 post-infection. B) At days 5 or 14 following infection, there were no significant differences in antigen-specific CD8+T cells expansion between the control and cancer groups. The mean frequencies in control vs. cancer were 6.97±1.49% vs. 6.89±2.49% at day 5, respectively and 5.38±0.73% vs. 4.90±1.19% at day 14, respectively; n = 8–10 at all time points.
    Pbs Bioxcell Invivomab Anti Mouse Cd8, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd8+antibody+in+pbs/InVivoMAb+anti-mouse+CD8/pmc09640547__41467_2022_34041_MOESM11_ESM-45-19-20
    Average 94 stars, based on 1 article reviews
    pbs bioxcell invivomab anti mouse cd8 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    90
    Becton Dickinson pacific blue (pb)-conjugated mouse anti-human cd8
    In silico and in vitro peptide analyses. a , b Venn diagrams of the number of a core peptide sequences that showed weak binding ( a ) and strong binding ( b ) to HLA-DRB1*12:01 and HLA-DRB1*12:02. The data were obtained from NetMHCIIpan version 4.0. c In silico analysis for seven common core peptides obtained from ( b ). The predicted B cell epitope amino acid positions were obtained by a BepiPred Linear Epitope Prediction 2.0. NA, not applicable; ND, not detected. d Schematic diagram of domain structures of SARS-CoV-2 Spike protein. NTD, N-terminal domain; RBD, receptor-binding domain; RBM, receptor-binding motif, SD, subdomain; S2′, S2′ protease cleavage site; FP, fusion peptide; HR, heptad repeat; CH, central helix; CD, connector domain; TM, transmembrane domain; CT, cytoplasmic tail. Numbers indicate the positions of the amino acid sequence. Triangles indicate the locations of common core peptides, the colors of which are black (strong binding to HLA-DR12, predicted B cell epitope, shared sequence with RBC membrane protein), gray (strong binding to HLA-DR12 and predicted B cell epitope), or white (strong binding to HLA-DR12 but not a predicted B cell epitope). e , f Flow cytometric analysis showing the expression of HLA-DR on CD4 + T cells ( e ) and <t>CD8</t> + T cells ( f ) that were pulsed with or without a TSNFR-containing peptide at the indicated concentrations
    Pacific Blue (Pb) Conjugated Mouse Anti Human Cd8, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd8+antibody+in+pbs/cd3+alexa+fluor+700+antibody/pmc09281373-26-33-39
    Average 90 stars, based on 1 article reviews
    pacific blue (pb)-conjugated mouse anti-human cd8 - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    Image Search Results


    Expression and functional characterization of CARs using different S-binders. (A) Schematic representation of CAR constructs. (B) Exemplary flow cytometry plots of retroviral transduction of primary human CD8 + T cells with C8-, 4D06-, and 4D08-CARs. (C) Transduction rates of CD4 + and CD8 + T cells from two healthy donors for C8-, 4D06-, and 4D08-CARs determined by flow cytometry. (D) Expression levels of C8-, 4D06-, and 4D08-CARs shown as mean fluorescence intensity (MFI) of CAR+ population (does not apply to mock cells). (E) 1x10 5 CAR-transduced T cells were cultured on plate-bound HBsAg titrated from 0.01-10 µg/ml. IFNγ secretion was measured after 48h by ELISA. Data points represent mean values ± SD from triplicates.

    Journal: Frontiers in Immunology

    Article Title: CARs derived from broadly neutralizing, human monoclonal antibodies identified by single B cell sorting target hepatitis B virus-positive cells

    doi: 10.3389/fimmu.2024.1340619

    Figure Lengend Snippet: Expression and functional characterization of CARs using different S-binders. (A) Schematic representation of CAR constructs. (B) Exemplary flow cytometry plots of retroviral transduction of primary human CD8 + T cells with C8-, 4D06-, and 4D08-CARs. (C) Transduction rates of CD4 + and CD8 + T cells from two healthy donors for C8-, 4D06-, and 4D08-CARs determined by flow cytometry. (D) Expression levels of C8-, 4D06-, and 4D08-CARs shown as mean fluorescence intensity (MFI) of CAR+ population (does not apply to mock cells). (E) 1x10 5 CAR-transduced T cells were cultured on plate-bound HBsAg titrated from 0.01-10 µg/ml. IFNγ secretion was measured after 48h by ELISA. Data points represent mean values ± SD from triplicates.

    Article Snippet: Surface staining was performed using anti-CD8-PB (BD), anti-CD4-AF700 (BioLegend) and anti-HA-PE (BioLegend) antibodies.

    Techniques: Expressing, Functional Assay, Construct, Flow Cytometry, Transduction, Fluorescence, Cell Culture, Enzyme-linked Immunosorbent Assay

    Functional evaluation of CARs from novel binders on HBsAg-expressing target cells. (A) CAR-transduced T cells were co-cultured at indicated effector-to-target (E:T) ratios on HepG2, HepG2-SML, or HepG2-2.15 cells. IFNγ secretion was measured via ELISA after 72h. Data points represent mean values ± SD from triplicates. (B) CAR-transduced T cells were pre-incubated with CellTrace Violet (CTV) and cultured at an E:T ratio of 2:1 on indicated target cells. Proliferation as a measure of CTV decrease was observed by flow cytometry after 72h. Histograms are representatives of duplicates. (C) Intracellular cytokine staining of CAR-transduced T cells co-cultured at an E:T ratio of 2:1 for 48h on indicated target cells (2 µg/ml Brefeldin A added after 24h). Statistical differences were calculated using unpaired student t-test; *=p≤0.05, **=p≤0.01, ***=p≤0.001. (D) Polyfunctionality of CAR-transduced T cells derived from intracellular cytokine staining described in (C) , indicating single (SP), double (DP), triple (TP), or quadruple positive (QP) populations of CD4 + or CD8 + CAR-transduced T cells incubated on HepG2-SML cells. (E) xCELLigence cytotoxicity assay of the different CAR-transduced T cells co-cultured at various E:T ratios for 96h with the indicated target cells. Data points represent mean values from triplicate analyses.

    Journal: Frontiers in Immunology

    Article Title: CARs derived from broadly neutralizing, human monoclonal antibodies identified by single B cell sorting target hepatitis B virus-positive cells

    doi: 10.3389/fimmu.2024.1340619

    Figure Lengend Snippet: Functional evaluation of CARs from novel binders on HBsAg-expressing target cells. (A) CAR-transduced T cells were co-cultured at indicated effector-to-target (E:T) ratios on HepG2, HepG2-SML, or HepG2-2.15 cells. IFNγ secretion was measured via ELISA after 72h. Data points represent mean values ± SD from triplicates. (B) CAR-transduced T cells were pre-incubated with CellTrace Violet (CTV) and cultured at an E:T ratio of 2:1 on indicated target cells. Proliferation as a measure of CTV decrease was observed by flow cytometry after 72h. Histograms are representatives of duplicates. (C) Intracellular cytokine staining of CAR-transduced T cells co-cultured at an E:T ratio of 2:1 for 48h on indicated target cells (2 µg/ml Brefeldin A added after 24h). Statistical differences were calculated using unpaired student t-test; *=p≤0.05, **=p≤0.01, ***=p≤0.001. (D) Polyfunctionality of CAR-transduced T cells derived from intracellular cytokine staining described in (C) , indicating single (SP), double (DP), triple (TP), or quadruple positive (QP) populations of CD4 + or CD8 + CAR-transduced T cells incubated on HepG2-SML cells. (E) xCELLigence cytotoxicity assay of the different CAR-transduced T cells co-cultured at various E:T ratios for 96h with the indicated target cells. Data points represent mean values from triplicate analyses.

    Article Snippet: Surface staining was performed using anti-CD8-PB (BD), anti-CD4-AF700 (BioLegend) and anti-HA-PE (BioLegend) antibodies.

    Techniques: Functional Assay, Expressing, Cell Culture, Enzyme-linked Immunosorbent Assay, Incubation, Flow Cytometry, Staining, Derivative Assay, Cytotoxicity Assay

    In vivo evaluation of CARs from novel binders in murine model of chronic HBV infection. Persistent HBV replication was established in Bl6.Rag1 - / - mice using AAV-HBV. 1x10 6 C8-, 4D06- or 4D08-CAR CD45.1 +/+ syngeneic T cells per mouse were transferred at week 5 after AAV-HBV infection (n=3). Two animals served as mock control. End-point analyses were performed at day 21 or 35 as indicated. Kinetics of (A) HBsAg, (B) HBeAg and (C) ALT levels in serum are given. (D) HBV pregenomic RNA (pgRNA) was quantified in liver tissue lysates obtained at day 35 through RT-PCR. (E) Immunohistochemistry of HBcAg expression in the liver of one representative animal per treatment group. Visible dark brown precipitates in the nucleus indicate HBV-positive hepatocytes. Scale bar represents 300 μm. (F) Number of HBcAg + hepatocytes per mm 2 as determined by quantitative analysis of immunohistochemistry stainings. (G) Frequencies of IFNγ-secreting CAR + CD8 + T cells from blood, liver or spleen detected by intracellular cytokine staining after 16h ex vivo stimulation with plate-bound HBsAg. Symbols and lines represent individual mice.

    Journal: Frontiers in Immunology

    Article Title: CARs derived from broadly neutralizing, human monoclonal antibodies identified by single B cell sorting target hepatitis B virus-positive cells

    doi: 10.3389/fimmu.2024.1340619

    Figure Lengend Snippet: In vivo evaluation of CARs from novel binders in murine model of chronic HBV infection. Persistent HBV replication was established in Bl6.Rag1 - / - mice using AAV-HBV. 1x10 6 C8-, 4D06- or 4D08-CAR CD45.1 +/+ syngeneic T cells per mouse were transferred at week 5 after AAV-HBV infection (n=3). Two animals served as mock control. End-point analyses were performed at day 21 or 35 as indicated. Kinetics of (A) HBsAg, (B) HBeAg and (C) ALT levels in serum are given. (D) HBV pregenomic RNA (pgRNA) was quantified in liver tissue lysates obtained at day 35 through RT-PCR. (E) Immunohistochemistry of HBcAg expression in the liver of one representative animal per treatment group. Visible dark brown precipitates in the nucleus indicate HBV-positive hepatocytes. Scale bar represents 300 μm. (F) Number of HBcAg + hepatocytes per mm 2 as determined by quantitative analysis of immunohistochemistry stainings. (G) Frequencies of IFNγ-secreting CAR + CD8 + T cells from blood, liver or spleen detected by intracellular cytokine staining after 16h ex vivo stimulation with plate-bound HBsAg. Symbols and lines represent individual mice.

    Article Snippet: Surface staining was performed using anti-CD8-PB (BD), anti-CD4-AF700 (BioLegend) and anti-HA-PE (BioLegend) antibodies.

    Techniques: In Vivo, Infection, Reverse Transcription Polymerase Chain Reaction, Immunohistochemistry, Expressing, Staining, Ex Vivo

    Sorted naive p14 CD8 T cells were transferred into CD45.1 recipient mice one day prior to intravenous infection with 2 × 10 6 PFU LCMV Cl13. Mice were euthanized at various time points after infection. Graphs show (A) representative flow cytometry plots (left) and the frequency (right) of p14 CD8 T cells present in the spleen of infected mice; (B) the percentage of KLRG1 + CD127 - p14 CD8 T cells expressing IRF-5; (C) the percentage of CD44 + CD127 + p14 CD8 T cells expressing IRF-5; and (D) the frequency of IRF-5 expression that colocalizes with DAPI staining over the course of LCMV Cl13 infection. Data represent the mean ± SEM of one of 2 or 3 independent experiments, n = 4-5.

    Journal: bioRxiv

    Article Title: The transcription factor IRF-5 is essential for the metabolic rewiring of CD8 T cells during chronic infection

    doi: 10.1101/2024.01.29.577789

    Figure Lengend Snippet: Sorted naive p14 CD8 T cells were transferred into CD45.1 recipient mice one day prior to intravenous infection with 2 × 10 6 PFU LCMV Cl13. Mice were euthanized at various time points after infection. Graphs show (A) representative flow cytometry plots (left) and the frequency (right) of p14 CD8 T cells present in the spleen of infected mice; (B) the percentage of KLRG1 + CD127 - p14 CD8 T cells expressing IRF-5; (C) the percentage of CD44 + CD127 + p14 CD8 T cells expressing IRF-5; and (D) the frequency of IRF-5 expression that colocalizes with DAPI staining over the course of LCMV Cl13 infection. Data represent the mean ± SEM of one of 2 or 3 independent experiments, n = 4-5.

    Article Snippet: The following fluorochrome-conjugated antibodies were used for surface staining anti CD3-Alexa fluor 700 (500A2, eBioscience), anti CD8-PB, aniti CD8-PE, anti CD8-APC (53-6.7, BD Bioscience), anti CD45.2-FITC (104, BD Bioscience), anti KLRG1-APC (2F1, eBioscience), anti CD127-PE (SB/199, BD Bioscience), anti LAG-3-PE-Cy7 (C9B7W, eBioscience), anti PD-1-biotin (29F.1A12, Biolegend), anti TIM-3-BV605 (RMT3-23, Biolegend), anti CD44-PE-Cy7 (IM7, BD Biosciences), anti CX3CR1-PerCP-Cy5.5 (SA011F11, Biolegend), anti CD101-Alexa flour 700 (Moushi101, eBioscience), and streptavidin-V500 (BD Bioscience).

    Techniques: Infection, Flow Cytometry, Expressing, Staining

    (A-B) Representative FACS plots and graphs representing IRF-5 expression by total splenocyte (A) and CD8 T cells (B) from WT ( Irf5 f/f x CMV-cre - ) and Irf5 -/- ( Irf5 f/f x CMV-cre + ) p14 transgenic mice. (C) Experimental set-up for adoptive transfer experiments described throughout the manuscript. (D) Graph illustrates the survival rate of male or female CD45.1 recipient mice adoptively transferred or not with WT and Irf5 -/- p14 CD8 T cells over the course of LCMV Cl13 infection. (E) Graph shows the percentage of KLRG1 + CD127 - WT and Irf5 -/- p14 CD8 T cells found in the spleen of recipient female mice over the course of infection

    Journal: bioRxiv

    Article Title: The transcription factor IRF-5 is essential for the metabolic rewiring of CD8 T cells during chronic infection

    doi: 10.1101/2024.01.29.577789

    Figure Lengend Snippet: (A-B) Representative FACS plots and graphs representing IRF-5 expression by total splenocyte (A) and CD8 T cells (B) from WT ( Irf5 f/f x CMV-cre - ) and Irf5 -/- ( Irf5 f/f x CMV-cre + ) p14 transgenic mice. (C) Experimental set-up for adoptive transfer experiments described throughout the manuscript. (D) Graph illustrates the survival rate of male or female CD45.1 recipient mice adoptively transferred or not with WT and Irf5 -/- p14 CD8 T cells over the course of LCMV Cl13 infection. (E) Graph shows the percentage of KLRG1 + CD127 - WT and Irf5 -/- p14 CD8 T cells found in the spleen of recipient female mice over the course of infection

    Article Snippet: The following fluorochrome-conjugated antibodies were used for surface staining anti CD3-Alexa fluor 700 (500A2, eBioscience), anti CD8-PB, aniti CD8-PE, anti CD8-APC (53-6.7, BD Bioscience), anti CD45.2-FITC (104, BD Bioscience), anti KLRG1-APC (2F1, eBioscience), anti CD127-PE (SB/199, BD Bioscience), anti LAG-3-PE-Cy7 (C9B7W, eBioscience), anti PD-1-biotin (29F.1A12, Biolegend), anti TIM-3-BV605 (RMT3-23, Biolegend), anti CD44-PE-Cy7 (IM7, BD Biosciences), anti CX3CR1-PerCP-Cy5.5 (SA011F11, Biolegend), anti CD101-Alexa flour 700 (Moushi101, eBioscience), and streptavidin-V500 (BD Bioscience).

    Techniques: Expressing, Transgenic Assay, Adoptive Transfer Assay, Infection

    CD8 T cells from male WT or Irf5 -/- p14 mice were transferred into CD45.1 mice one day prior to intravenous infection with 2 × 10 6 PFU LCMV Cl13. Mice were euthanized at various time points after infection. Graphs show (A) representative FACS plots for splenocytes stained with anti CD8 and anti CD45.2; the percentage (B) and the absolute numbers (C) of adoptively transferred WT and Irf5 -/- p14 CD8 T cells present in the spleen of infected recipient mice; (D) representative flow cytometry plots and corresponding percentages of KLRG1 + CD127 - (E) and CD127 + CD44 + (F) p14 CD8 T cells in the spleen of recipient mice over the course of LCMV infection. Data represents the mean ± SEM, n=4-5, one of 3 independent experiments is shown. * denotes p <0.05, ** denotes p <0.01 *** denotes p< 0.001 **** denotes p < 0.0001.

    Journal: bioRxiv

    Article Title: The transcription factor IRF-5 is essential for the metabolic rewiring of CD8 T cells during chronic infection

    doi: 10.1101/2024.01.29.577789

    Figure Lengend Snippet: CD8 T cells from male WT or Irf5 -/- p14 mice were transferred into CD45.1 mice one day prior to intravenous infection with 2 × 10 6 PFU LCMV Cl13. Mice were euthanized at various time points after infection. Graphs show (A) representative FACS plots for splenocytes stained with anti CD8 and anti CD45.2; the percentage (B) and the absolute numbers (C) of adoptively transferred WT and Irf5 -/- p14 CD8 T cells present in the spleen of infected recipient mice; (D) representative flow cytometry plots and corresponding percentages of KLRG1 + CD127 - (E) and CD127 + CD44 + (F) p14 CD8 T cells in the spleen of recipient mice over the course of LCMV infection. Data represents the mean ± SEM, n=4-5, one of 3 independent experiments is shown. * denotes p <0.05, ** denotes p <0.01 *** denotes p< 0.001 **** denotes p < 0.0001.

    Article Snippet: The following fluorochrome-conjugated antibodies were used for surface staining anti CD3-Alexa fluor 700 (500A2, eBioscience), anti CD8-PB, aniti CD8-PE, anti CD8-APC (53-6.7, BD Bioscience), anti CD45.2-FITC (104, BD Bioscience), anti KLRG1-APC (2F1, eBioscience), anti CD127-PE (SB/199, BD Bioscience), anti LAG-3-PE-Cy7 (C9B7W, eBioscience), anti PD-1-biotin (29F.1A12, Biolegend), anti TIM-3-BV605 (RMT3-23, Biolegend), anti CD44-PE-Cy7 (IM7, BD Biosciences), anti CX3CR1-PerCP-Cy5.5 (SA011F11, Biolegend), anti CD101-Alexa flour 700 (Moushi101, eBioscience), and streptavidin-V500 (BD Bioscience).

    Techniques: Infection, Staining, Flow Cytometry

    I r f5f /f x Lck-Cre - (WT) and Irf5 f/f x Lck-Cre + (Lck-cre + ) mice were infected intravenously with 2 × 10 6 PFU LCMV Cl13 and euthanized at various time points p.i.. Graphs show (A) representative FACS plots for CD8 T cell staining, and (B) the percentages and (C) absolute numbers of CD8 T cells found in the spleen over the course of infection.

    Journal: bioRxiv

    Article Title: The transcription factor IRF-5 is essential for the metabolic rewiring of CD8 T cells during chronic infection

    doi: 10.1101/2024.01.29.577789

    Figure Lengend Snippet: I r f5f /f x Lck-Cre - (WT) and Irf5 f/f x Lck-Cre + (Lck-cre + ) mice were infected intravenously with 2 × 10 6 PFU LCMV Cl13 and euthanized at various time points p.i.. Graphs show (A) representative FACS plots for CD8 T cell staining, and (B) the percentages and (C) absolute numbers of CD8 T cells found in the spleen over the course of infection.

    Article Snippet: The following fluorochrome-conjugated antibodies were used for surface staining anti CD3-Alexa fluor 700 (500A2, eBioscience), anti CD8-PB, aniti CD8-PE, anti CD8-APC (53-6.7, BD Bioscience), anti CD45.2-FITC (104, BD Bioscience), anti KLRG1-APC (2F1, eBioscience), anti CD127-PE (SB/199, BD Bioscience), anti LAG-3-PE-Cy7 (C9B7W, eBioscience), anti PD-1-biotin (29F.1A12, Biolegend), anti TIM-3-BV605 (RMT3-23, Biolegend), anti CD44-PE-Cy7 (IM7, BD Biosciences), anti CX3CR1-PerCP-Cy5.5 (SA011F11, Biolegend), anti CD101-Alexa flour 700 (Moushi101, eBioscience), and streptavidin-V500 (BD Bioscience).

    Techniques: Infection, Staining

    CD8 T cells from male WT or Irf5 -/- p14 mice were adoptively transferred into CD45.1 recipient mice one day prior to intravenous infection with 2 × 10 6 PFU LCMV Cl13. Mice were euthanized at various time points after infection. (A-F) Cytokine production by adoptively transferred p14 cells was assessed after restimulation with the gp33 peptide. (A) Representative FACS plot for the various cytokine staining at d30 p.i.. (B-D) Graphs show the frequency (upper graphs) and mean fluorescence intensity (MFI) (lower graphs) of IFN-γ + (B), TNF + (C), and IL-2 + (D) WT p14 and Irf5 -/− p14 CD8 T cells at various days post infection. (E-F) Graphs represent the percentage of IFN-γ + TNF + (E) and IFN-γ + TNF + IL-2 + (F) WT p14 and Irf5 -/− p14 CD8 T cells at various days post infection. (G-I) Expression of inhibitory receptors in WT and Irf5 -/− p14 CD8 T cells. Graphs represent the frequency of Tim3 + PD1 + (G), Lag3 + PD1 + (H), and Tim3 + Lag3 + PD1 + (I) adoptively transferred WT p14 and Irf5 -/− p14 cells over the course of infection. (J-L) Representative flow cytometry plots and graphs showing the percentage of CX3CR1 + effector-like (J and K) and CD101 + terminally exhausted (J and L) WT and Irf5 -/− p14 CD8 T cells at various time points post infection. Data represent the mean ± SEM, n=4-5, one of 3 independent experiments is shown, * denotes p <0.05, ** denotes p <0.01 *** denotes p< 0.001 **** denotes p < 0.0001.

    Journal: bioRxiv

    Article Title: The transcription factor IRF-5 is essential for the metabolic rewiring of CD8 T cells during chronic infection

    doi: 10.1101/2024.01.29.577789

    Figure Lengend Snippet: CD8 T cells from male WT or Irf5 -/- p14 mice were adoptively transferred into CD45.1 recipient mice one day prior to intravenous infection with 2 × 10 6 PFU LCMV Cl13. Mice were euthanized at various time points after infection. (A-F) Cytokine production by adoptively transferred p14 cells was assessed after restimulation with the gp33 peptide. (A) Representative FACS plot for the various cytokine staining at d30 p.i.. (B-D) Graphs show the frequency (upper graphs) and mean fluorescence intensity (MFI) (lower graphs) of IFN-γ + (B), TNF + (C), and IL-2 + (D) WT p14 and Irf5 -/− p14 CD8 T cells at various days post infection. (E-F) Graphs represent the percentage of IFN-γ + TNF + (E) and IFN-γ + TNF + IL-2 + (F) WT p14 and Irf5 -/− p14 CD8 T cells at various days post infection. (G-I) Expression of inhibitory receptors in WT and Irf5 -/− p14 CD8 T cells. Graphs represent the frequency of Tim3 + PD1 + (G), Lag3 + PD1 + (H), and Tim3 + Lag3 + PD1 + (I) adoptively transferred WT p14 and Irf5 -/− p14 cells over the course of infection. (J-L) Representative flow cytometry plots and graphs showing the percentage of CX3CR1 + effector-like (J and K) and CD101 + terminally exhausted (J and L) WT and Irf5 -/− p14 CD8 T cells at various time points post infection. Data represent the mean ± SEM, n=4-5, one of 3 independent experiments is shown, * denotes p <0.05, ** denotes p <0.01 *** denotes p< 0.001 **** denotes p < 0.0001.

    Article Snippet: The following fluorochrome-conjugated antibodies were used for surface staining anti CD3-Alexa fluor 700 (500A2, eBioscience), anti CD8-PB, aniti CD8-PE, anti CD8-APC (53-6.7, BD Bioscience), anti CD45.2-FITC (104, BD Bioscience), anti KLRG1-APC (2F1, eBioscience), anti CD127-PE (SB/199, BD Bioscience), anti LAG-3-PE-Cy7 (C9B7W, eBioscience), anti PD-1-biotin (29F.1A12, Biolegend), anti TIM-3-BV605 (RMT3-23, Biolegend), anti CD44-PE-Cy7 (IM7, BD Biosciences), anti CX3CR1-PerCP-Cy5.5 (SA011F11, Biolegend), anti CD101-Alexa flour 700 (Moushi101, eBioscience), and streptavidin-V500 (BD Bioscience).

    Techniques: Infection, Staining, Fluorescence, Expressing, Flow Cytometry

    CD8 T cells from female WT or Irf5 -/- p14 mice were adoptively transferred into CD45.1 recipient mice one day prior to intravenous infection with 2 × 10 6 PFU LCMV Cl13. Mice were euthanized at various time points after infection. Graphs show the frequency of (A) IFNγ + , (B) TNF + , and (F) IL-2 + CD8 T cells upon in vitro restimulation with the gp33 peptide; and the percentage of (D) CX3CR1 + and (E) CD101 + splenic CD8 T cells.

    Journal: bioRxiv

    Article Title: The transcription factor IRF-5 is essential for the metabolic rewiring of CD8 T cells during chronic infection

    doi: 10.1101/2024.01.29.577789

    Figure Lengend Snippet: CD8 T cells from female WT or Irf5 -/- p14 mice were adoptively transferred into CD45.1 recipient mice one day prior to intravenous infection with 2 × 10 6 PFU LCMV Cl13. Mice were euthanized at various time points after infection. Graphs show the frequency of (A) IFNγ + , (B) TNF + , and (F) IL-2 + CD8 T cells upon in vitro restimulation with the gp33 peptide; and the percentage of (D) CX3CR1 + and (E) CD101 + splenic CD8 T cells.

    Article Snippet: The following fluorochrome-conjugated antibodies were used for surface staining anti CD3-Alexa fluor 700 (500A2, eBioscience), anti CD8-PB, aniti CD8-PE, anti CD8-APC (53-6.7, BD Bioscience), anti CD45.2-FITC (104, BD Bioscience), anti KLRG1-APC (2F1, eBioscience), anti CD127-PE (SB/199, BD Bioscience), anti LAG-3-PE-Cy7 (C9B7W, eBioscience), anti PD-1-biotin (29F.1A12, Biolegend), anti TIM-3-BV605 (RMT3-23, Biolegend), anti CD44-PE-Cy7 (IM7, BD Biosciences), anti CX3CR1-PerCP-Cy5.5 (SA011F11, Biolegend), anti CD101-Alexa flour 700 (Moushi101, eBioscience), and streptavidin-V500 (BD Bioscience).

    Techniques: Infection, In Vitro

    Graphs illustrate the frequency of (A) IRF-4 + , (B) Eomes + , and (C) T-bet + WT and Irf5 -/- p14 CD8 T cells found in the spleen of recipient mice at various time points after LCMV Cl 13 infection.

    Journal: bioRxiv

    Article Title: The transcription factor IRF-5 is essential for the metabolic rewiring of CD8 T cells during chronic infection

    doi: 10.1101/2024.01.29.577789

    Figure Lengend Snippet: Graphs illustrate the frequency of (A) IRF-4 + , (B) Eomes + , and (C) T-bet + WT and Irf5 -/- p14 CD8 T cells found in the spleen of recipient mice at various time points after LCMV Cl 13 infection.

    Article Snippet: The following fluorochrome-conjugated antibodies were used for surface staining anti CD3-Alexa fluor 700 (500A2, eBioscience), anti CD8-PB, aniti CD8-PE, anti CD8-APC (53-6.7, BD Bioscience), anti CD45.2-FITC (104, BD Bioscience), anti KLRG1-APC (2F1, eBioscience), anti CD127-PE (SB/199, BD Bioscience), anti LAG-3-PE-Cy7 (C9B7W, eBioscience), anti PD-1-biotin (29F.1A12, Biolegend), anti TIM-3-BV605 (RMT3-23, Biolegend), anti CD44-PE-Cy7 (IM7, BD Biosciences), anti CX3CR1-PerCP-Cy5.5 (SA011F11, Biolegend), anti CD101-Alexa flour 700 (Moushi101, eBioscience), and streptavidin-V500 (BD Bioscience).

    Techniques: Infection

    I r f5f /f x Lck-Cre - (WT) and Irf5 f/f x Lck-Cre + (Lck-cre + ) mice were infected intravenously with 2 × 10 6 PFU LCMV Cl13 and euthanized at various time points p.i.. Graphs show the frequency of (A) IFNγ + , (B) TNF + , and (F) IFNγ + TNF + CD8 T cells upon ex vivo restimulation with the gp33 peptide; the percentage of gp33-tetramer + splenic CD8 T cells expressing (D) PD-1, (E) TIM-3, and (F) LAG-3 over the course of infection. (G) Viral titers were assessed in the serum of infected mice until d60 p.i.

    Journal: bioRxiv

    Article Title: The transcription factor IRF-5 is essential for the metabolic rewiring of CD8 T cells during chronic infection

    doi: 10.1101/2024.01.29.577789

    Figure Lengend Snippet: I r f5f /f x Lck-Cre - (WT) and Irf5 f/f x Lck-Cre + (Lck-cre + ) mice were infected intravenously with 2 × 10 6 PFU LCMV Cl13 and euthanized at various time points p.i.. Graphs show the frequency of (A) IFNγ + , (B) TNF + , and (F) IFNγ + TNF + CD8 T cells upon ex vivo restimulation with the gp33 peptide; the percentage of gp33-tetramer + splenic CD8 T cells expressing (D) PD-1, (E) TIM-3, and (F) LAG-3 over the course of infection. (G) Viral titers were assessed in the serum of infected mice until d60 p.i.

    Article Snippet: The following fluorochrome-conjugated antibodies were used for surface staining anti CD3-Alexa fluor 700 (500A2, eBioscience), anti CD8-PB, aniti CD8-PE, anti CD8-APC (53-6.7, BD Bioscience), anti CD45.2-FITC (104, BD Bioscience), anti KLRG1-APC (2F1, eBioscience), anti CD127-PE (SB/199, BD Bioscience), anti LAG-3-PE-Cy7 (C9B7W, eBioscience), anti PD-1-biotin (29F.1A12, Biolegend), anti TIM-3-BV605 (RMT3-23, Biolegend), anti CD44-PE-Cy7 (IM7, BD Biosciences), anti CX3CR1-PerCP-Cy5.5 (SA011F11, Biolegend), anti CD101-Alexa flour 700 (Moushi101, eBioscience), and streptavidin-V500 (BD Bioscience).

    Techniques: Infection, Ex Vivo, Expressing

    The heatmap shows the top 45 differentially expressed genes with padj values smaller than 0.05) in WT and Irf5 -/- p14 CD8 T cells isolated from female and male recipient mice at d21 p.i..

    Journal: bioRxiv

    Article Title: The transcription factor IRF-5 is essential for the metabolic rewiring of CD8 T cells during chronic infection

    doi: 10.1101/2024.01.29.577789

    Figure Lengend Snippet: The heatmap shows the top 45 differentially expressed genes with padj values smaller than 0.05) in WT and Irf5 -/- p14 CD8 T cells isolated from female and male recipient mice at d21 p.i..

    Article Snippet: The following fluorochrome-conjugated antibodies were used for surface staining anti CD3-Alexa fluor 700 (500A2, eBioscience), anti CD8-PB, aniti CD8-PE, anti CD8-APC (53-6.7, BD Bioscience), anti CD45.2-FITC (104, BD Bioscience), anti KLRG1-APC (2F1, eBioscience), anti CD127-PE (SB/199, BD Bioscience), anti LAG-3-PE-Cy7 (C9B7W, eBioscience), anti PD-1-biotin (29F.1A12, Biolegend), anti TIM-3-BV605 (RMT3-23, Biolegend), anti CD44-PE-Cy7 (IM7, BD Biosciences), anti CX3CR1-PerCP-Cy5.5 (SA011F11, Biolegend), anti CD101-Alexa flour 700 (Moushi101, eBioscience), and streptavidin-V500 (BD Bioscience).

    Techniques: Isolation

    (A-B) Bulk RNA sequencing was performed on adoptively transferred WT p14 and Irf5 -/- p14 CD8 T cells isolated from male and female recipient mice at day 21 after LCMV Cl13 infection. (A) Gene ontology analysis results showing biological processes that were mostly upregulated in the absence of IRF-5. (B) Heat map illustrating the relative expression of genes involved in the cell cycle in WT and Irf5 -/- p14 CD8 T cells. (C) WT and Irf5 -/- p14 CD8 T cells were adoptively transferred into CD45.1 recipient mice a day prior to infection with LCMV Cl13. Mice were then euthanized at various time point after infection. Graphs show representative flow cytometry plots for Ki67 and DAPI staining (upper graphs) and the proportion of cells in the various phases of the cell cycle at any given time point (lower graph). (D) Graph displays the cell cycle analysis based on Ki67 and DAPI staining of WT and Irf5 -/- p14 CD8 T cells stimulated in vitro with or without the gp33 peptide. Data represent the mean ± SEM, n=4-5, one of 3 independent experiments is shown, * denotes p <0.05, ** denotes p <0.01.

    Journal: bioRxiv

    Article Title: The transcription factor IRF-5 is essential for the metabolic rewiring of CD8 T cells during chronic infection

    doi: 10.1101/2024.01.29.577789

    Figure Lengend Snippet: (A-B) Bulk RNA sequencing was performed on adoptively transferred WT p14 and Irf5 -/- p14 CD8 T cells isolated from male and female recipient mice at day 21 after LCMV Cl13 infection. (A) Gene ontology analysis results showing biological processes that were mostly upregulated in the absence of IRF-5. (B) Heat map illustrating the relative expression of genes involved in the cell cycle in WT and Irf5 -/- p14 CD8 T cells. (C) WT and Irf5 -/- p14 CD8 T cells were adoptively transferred into CD45.1 recipient mice a day prior to infection with LCMV Cl13. Mice were then euthanized at various time point after infection. Graphs show representative flow cytometry plots for Ki67 and DAPI staining (upper graphs) and the proportion of cells in the various phases of the cell cycle at any given time point (lower graph). (D) Graph displays the cell cycle analysis based on Ki67 and DAPI staining of WT and Irf5 -/- p14 CD8 T cells stimulated in vitro with or without the gp33 peptide. Data represent the mean ± SEM, n=4-5, one of 3 independent experiments is shown, * denotes p <0.05, ** denotes p <0.01.

    Article Snippet: The following fluorochrome-conjugated antibodies were used for surface staining anti CD3-Alexa fluor 700 (500A2, eBioscience), anti CD8-PB, aniti CD8-PE, anti CD8-APC (53-6.7, BD Bioscience), anti CD45.2-FITC (104, BD Bioscience), anti KLRG1-APC (2F1, eBioscience), anti CD127-PE (SB/199, BD Bioscience), anti LAG-3-PE-Cy7 (C9B7W, eBioscience), anti PD-1-biotin (29F.1A12, Biolegend), anti TIM-3-BV605 (RMT3-23, Biolegend), anti CD44-PE-Cy7 (IM7, BD Biosciences), anti CX3CR1-PerCP-Cy5.5 (SA011F11, Biolegend), anti CD101-Alexa flour 700 (Moushi101, eBioscience), and streptavidin-V500 (BD Bioscience).

    Techniques: RNA Sequencing Assay, Isolation, Infection, Expressing, Flow Cytometry, Staining, Cell Cycle Assay, In Vitro

    Transcriptional profiling was performed on adoptively transferred WT p14 and Irf5 -/- p14 CD8 T cells isolated from male and female recipient mice at day 21 post LCMV Cl13 infection. (A-D) Heatmaps displaying expression of relative upregulated and down regulated signature gene sets involved in (A) CD8 T cell exhaustion, (B) cell death, (C) cellular carbohydrate metabolic processes, and (D) lipid metabolic processes. (E) WT and Irf5 -/- p14 CD8 T cells were adoptively transferred into female CD45.1 recipient mice a day prior to infection with LCMV Cl13. Adoptively transferred cells were then sorted at d21 p.i and the mRNA expressions of Gpat2 (left graph), Awat2 (center graph), and Gpld1 (right graph) were analyzed by digital droplet PCR. Data represents the mean ± SEM, * denotes p <0.05.

    Journal: bioRxiv

    Article Title: The transcription factor IRF-5 is essential for the metabolic rewiring of CD8 T cells during chronic infection

    doi: 10.1101/2024.01.29.577789

    Figure Lengend Snippet: Transcriptional profiling was performed on adoptively transferred WT p14 and Irf5 -/- p14 CD8 T cells isolated from male and female recipient mice at day 21 post LCMV Cl13 infection. (A-D) Heatmaps displaying expression of relative upregulated and down regulated signature gene sets involved in (A) CD8 T cell exhaustion, (B) cell death, (C) cellular carbohydrate metabolic processes, and (D) lipid metabolic processes. (E) WT and Irf5 -/- p14 CD8 T cells were adoptively transferred into female CD45.1 recipient mice a day prior to infection with LCMV Cl13. Adoptively transferred cells were then sorted at d21 p.i and the mRNA expressions of Gpat2 (left graph), Awat2 (center graph), and Gpld1 (right graph) were analyzed by digital droplet PCR. Data represents the mean ± SEM, * denotes p <0.05.

    Article Snippet: The following fluorochrome-conjugated antibodies were used for surface staining anti CD3-Alexa fluor 700 (500A2, eBioscience), anti CD8-PB, aniti CD8-PE, anti CD8-APC (53-6.7, BD Bioscience), anti CD45.2-FITC (104, BD Bioscience), anti KLRG1-APC (2F1, eBioscience), anti CD127-PE (SB/199, BD Bioscience), anti LAG-3-PE-Cy7 (C9B7W, eBioscience), anti PD-1-biotin (29F.1A12, Biolegend), anti TIM-3-BV605 (RMT3-23, Biolegend), anti CD44-PE-Cy7 (IM7, BD Biosciences), anti CX3CR1-PerCP-Cy5.5 (SA011F11, Biolegend), anti CD101-Alexa flour 700 (Moushi101, eBioscience), and streptavidin-V500 (BD Bioscience).

    Techniques: Isolation, Infection, Expressing

    WT p14 and Irf5 -/- p14 CD8 purified from female mice were cultured in vitro in the presence or absence of the gp33 peptide, and the mitochondria respiratory capacity was measured using the Seahorse XFe-96 analyzer. Graphs illustrate (A) the representative oxygen consumption rates (OCR) and (B) the extracellular acidification rates (ECAR) over time; (C) the basal and (D) maximal respiration, and (E) the ATP production at 6h and 24h after stimulation with the gp33 peptide; (F) the ATP production rate; and (G) the glucose (measured using the fluorescent glucose analog 2-NBDG) and (H) the fatty acid uptake capacity (quantified using bodipy FLC 16 fluorescence intensity). Data represent the mean ± SEM, n=4, one of three independent experiments is shown, * denotes p <0.05, **** denotes p <0.0001

    Journal: bioRxiv

    Article Title: The transcription factor IRF-5 is essential for the metabolic rewiring of CD8 T cells during chronic infection

    doi: 10.1101/2024.01.29.577789

    Figure Lengend Snippet: WT p14 and Irf5 -/- p14 CD8 purified from female mice were cultured in vitro in the presence or absence of the gp33 peptide, and the mitochondria respiratory capacity was measured using the Seahorse XFe-96 analyzer. Graphs illustrate (A) the representative oxygen consumption rates (OCR) and (B) the extracellular acidification rates (ECAR) over time; (C) the basal and (D) maximal respiration, and (E) the ATP production at 6h and 24h after stimulation with the gp33 peptide; (F) the ATP production rate; and (G) the glucose (measured using the fluorescent glucose analog 2-NBDG) and (H) the fatty acid uptake capacity (quantified using bodipy FLC 16 fluorescence intensity). Data represent the mean ± SEM, n=4, one of three independent experiments is shown, * denotes p <0.05, **** denotes p <0.0001

    Article Snippet: The following fluorochrome-conjugated antibodies were used for surface staining anti CD3-Alexa fluor 700 (500A2, eBioscience), anti CD8-PB, aniti CD8-PE, anti CD8-APC (53-6.7, BD Bioscience), anti CD45.2-FITC (104, BD Bioscience), anti KLRG1-APC (2F1, eBioscience), anti CD127-PE (SB/199, BD Bioscience), anti LAG-3-PE-Cy7 (C9B7W, eBioscience), anti PD-1-biotin (29F.1A12, Biolegend), anti TIM-3-BV605 (RMT3-23, Biolegend), anti CD44-PE-Cy7 (IM7, BD Biosciences), anti CX3CR1-PerCP-Cy5.5 (SA011F11, Biolegend), anti CD101-Alexa flour 700 (Moushi101, eBioscience), and streptavidin-V500 (BD Bioscience).

    Techniques: Purification, Cell Culture, In Vitro, Fluorescence

    WT and Irf5 -/- p14 CD8 T cells purified from male mice were cultured in vitro in the presence or absence of the gp33 peptide, and the mitochondria respiratory capacity was measured using the Seahorse XFe-96 analyzer. Graphs illustrate (A) the representative oxygen consumption rates (OCR) and (B) the extracellular acidification rates (ECAR) over time; (C) the basal and (D) maximal respiration, and (E) the ATP production at 6h and 24h after stimulation with the gp33 peptide; (F) the ATP production rate; and (G) the glucose (measured using the fluorescent glucose analog 2-NBDG) and (H) the fatty acid uptake capacity (quantified using bodipy FLC 16 fluorescence intensity).

    Journal: bioRxiv

    Article Title: The transcription factor IRF-5 is essential for the metabolic rewiring of CD8 T cells during chronic infection

    doi: 10.1101/2024.01.29.577789

    Figure Lengend Snippet: WT and Irf5 -/- p14 CD8 T cells purified from male mice were cultured in vitro in the presence or absence of the gp33 peptide, and the mitochondria respiratory capacity was measured using the Seahorse XFe-96 analyzer. Graphs illustrate (A) the representative oxygen consumption rates (OCR) and (B) the extracellular acidification rates (ECAR) over time; (C) the basal and (D) maximal respiration, and (E) the ATP production at 6h and 24h after stimulation with the gp33 peptide; (F) the ATP production rate; and (G) the glucose (measured using the fluorescent glucose analog 2-NBDG) and (H) the fatty acid uptake capacity (quantified using bodipy FLC 16 fluorescence intensity).

    Article Snippet: The following fluorochrome-conjugated antibodies were used for surface staining anti CD3-Alexa fluor 700 (500A2, eBioscience), anti CD8-PB, aniti CD8-PE, anti CD8-APC (53-6.7, BD Bioscience), anti CD45.2-FITC (104, BD Bioscience), anti KLRG1-APC (2F1, eBioscience), anti CD127-PE (SB/199, BD Bioscience), anti LAG-3-PE-Cy7 (C9B7W, eBioscience), anti PD-1-biotin (29F.1A12, Biolegend), anti TIM-3-BV605 (RMT3-23, Biolegend), anti CD44-PE-Cy7 (IM7, BD Biosciences), anti CX3CR1-PerCP-Cy5.5 (SA011F11, Biolegend), anti CD101-Alexa flour 700 (Moushi101, eBioscience), and streptavidin-V500 (BD Bioscience).

    Techniques: Purification, Cell Culture, In Vitro, Fluorescence

    (A) Bulk RNA sequencing data of adoptively transferred WT and Irf5 -/- p14 CD8 T cells isolated from recipient female and male mice at d21 p.i. were analyzed for the expression of signature gene sets associated with the mitochondrial envelop. The heatmap illustrate up- and down-regulated genes. (B-H) WT or Irf5 -/- p14 CD8 T cells were adoptively transferred into female CD45.1 mice a day prior to infection with LCMV Cl13. Mice were then euthanized at d21 p.i (B-C) and d15 p.i. (D-H) and adoptively transferred cells were sorted. Graphs represent (B) mRNA expressions of Coq4 (left graph), Ndufaf3 (center graph), Ndufb4 (right graph) and (C) Ghitm measured by digital droplet PCR; (D) the mitochondrial membrane potential, determined by TMRM mean fluorescence intensity; (E) the mitochondrial ROS production, assessed by mtSOX fluorescence intensity; (F) the glucose uptake capacity, measured using the glucose analog 2-NBDG; (G) the bodipy FLC 16 mean fluorescence intensity as an indicator of the fatty acid uptake capacity; and (H) the relative cellular lipid peroxidation level, detected using Image-iT™ Lipid Peroxidation Kit and calculated using the ratio of the signal from the 590 nm and 510 nm channels (lower ratios indicate higher lipid peroxidation levels). Data represent the mean ± SEM, n=5, * denotes p <0.05, ** denotes p <0.01

    Journal: bioRxiv

    Article Title: The transcription factor IRF-5 is essential for the metabolic rewiring of CD8 T cells during chronic infection

    doi: 10.1101/2024.01.29.577789

    Figure Lengend Snippet: (A) Bulk RNA sequencing data of adoptively transferred WT and Irf5 -/- p14 CD8 T cells isolated from recipient female and male mice at d21 p.i. were analyzed for the expression of signature gene sets associated with the mitochondrial envelop. The heatmap illustrate up- and down-regulated genes. (B-H) WT or Irf5 -/- p14 CD8 T cells were adoptively transferred into female CD45.1 mice a day prior to infection with LCMV Cl13. Mice were then euthanized at d21 p.i (B-C) and d15 p.i. (D-H) and adoptively transferred cells were sorted. Graphs represent (B) mRNA expressions of Coq4 (left graph), Ndufaf3 (center graph), Ndufb4 (right graph) and (C) Ghitm measured by digital droplet PCR; (D) the mitochondrial membrane potential, determined by TMRM mean fluorescence intensity; (E) the mitochondrial ROS production, assessed by mtSOX fluorescence intensity; (F) the glucose uptake capacity, measured using the glucose analog 2-NBDG; (G) the bodipy FLC 16 mean fluorescence intensity as an indicator of the fatty acid uptake capacity; and (H) the relative cellular lipid peroxidation level, detected using Image-iT™ Lipid Peroxidation Kit and calculated using the ratio of the signal from the 590 nm and 510 nm channels (lower ratios indicate higher lipid peroxidation levels). Data represent the mean ± SEM, n=5, * denotes p <0.05, ** denotes p <0.01

    Article Snippet: The following fluorochrome-conjugated antibodies were used for surface staining anti CD3-Alexa fluor 700 (500A2, eBioscience), anti CD8-PB, aniti CD8-PE, anti CD8-APC (53-6.7, BD Bioscience), anti CD45.2-FITC (104, BD Bioscience), anti KLRG1-APC (2F1, eBioscience), anti CD127-PE (SB/199, BD Bioscience), anti LAG-3-PE-Cy7 (C9B7W, eBioscience), anti PD-1-biotin (29F.1A12, Biolegend), anti TIM-3-BV605 (RMT3-23, Biolegend), anti CD44-PE-Cy7 (IM7, BD Biosciences), anti CX3CR1-PerCP-Cy5.5 (SA011F11, Biolegend), anti CD101-Alexa flour 700 (Moushi101, eBioscience), and streptavidin-V500 (BD Bioscience).

    Techniques: RNA Sequencing Assay, Isolation, Expressing, Infection, Membrane, Fluorescence

    Vaccination of C57Bl/6 mice with rMVA-HBc±CD70. ( A ) C57Bl/6 mice were immunized subcutaneously with HBcAg adjuvanted with CpG and PCEP at day 0 (group wt received adjuvants only). At day 21, mice were boosted with MVAwt (group wt), rMVA-HBc (group HBc) or rMVA-HBc-CD70 (group HBc-CD70) by intraperitoneal injection. At day 35, splenocytes of mice were isolated and stained with PE-labelled C 93 multimers to determine the amount of HBc-specific CD8 T cells ( B ) showing representative dot plots and ( C ) showing the group analysis. The table ( C ) shows the proportion of all CD8+ T cells. At day 35, splenocytes of vaccinated mice were also stimulated ex vivo with C 93 or B8R peptides for intracellular cytokine staining (ICS) to evaluate C 93 - or B8R- specific IFNγ-, TNFα- and IL2 production of CD8 T cells ( D ) showing representative dot plots and ( E ) showing the group analysis. ( F ) Simultaneous detection of IFNγ, TNFα and IL2 production of CD8 cells upon HBc stimulation ex vivo: dot plots show one representative mouse of each group. The table shows the mean values (% of CD8+ cells) of 4 mice/group. ( G ) The gain of function of CD8 T cells after CD70 co-stimulation during vaccination: the proportion of IFNγ+ CD8 T cells upon ex vivo C 93 stimulation was set in relation to the proportion of C 93 multimer-positive CD8 T cells in the same animals. Proportions were calculated for each mouse separately. C 93 : HBcAg CD8 T cell epitope; B8R: MVA-derived CD8 T cell epitope. Crosses and triangles represent individual mice; horizontal lines indicate mean values; error bars indicate standard deviation. Statistics: one-way ANOVA and subsequent unpaired t-test, n.s.: not statistically significant.

    Journal: Vaccines

    Article Title: Evaluation of the Effect of CD70 Co-Expression on CD8 T Cell Response in Protein-Prime MVA-Boost Vaccination in Mice

    doi: 10.3390/vaccines11020245

    Figure Lengend Snippet: Vaccination of C57Bl/6 mice with rMVA-HBc±CD70. ( A ) C57Bl/6 mice were immunized subcutaneously with HBcAg adjuvanted with CpG and PCEP at day 0 (group wt received adjuvants only). At day 21, mice were boosted with MVAwt (group wt), rMVA-HBc (group HBc) or rMVA-HBc-CD70 (group HBc-CD70) by intraperitoneal injection. At day 35, splenocytes of mice were isolated and stained with PE-labelled C 93 multimers to determine the amount of HBc-specific CD8 T cells ( B ) showing representative dot plots and ( C ) showing the group analysis. The table ( C ) shows the proportion of all CD8+ T cells. At day 35, splenocytes of vaccinated mice were also stimulated ex vivo with C 93 or B8R peptides for intracellular cytokine staining (ICS) to evaluate C 93 - or B8R- specific IFNγ-, TNFα- and IL2 production of CD8 T cells ( D ) showing representative dot plots and ( E ) showing the group analysis. ( F ) Simultaneous detection of IFNγ, TNFα and IL2 production of CD8 cells upon HBc stimulation ex vivo: dot plots show one representative mouse of each group. The table shows the mean values (% of CD8+ cells) of 4 mice/group. ( G ) The gain of function of CD8 T cells after CD70 co-stimulation during vaccination: the proportion of IFNγ+ CD8 T cells upon ex vivo C 93 stimulation was set in relation to the proportion of C 93 multimer-positive CD8 T cells in the same animals. Proportions were calculated for each mouse separately. C 93 : HBcAg CD8 T cell epitope; B8R: MVA-derived CD8 T cell epitope. Crosses and triangles represent individual mice; horizontal lines indicate mean values; error bars indicate standard deviation. Statistics: one-way ANOVA and subsequent unpaired t-test, n.s.: not statistically significant.

    Article Snippet: Surface markers were stained with PB-conjugated anti-CD8 T cell antibody (clone 56.6-7, BD Biosciences, Heidelberg, Germany) and anti-CD4-PE (eBioscience, San Diego, USA).

    Techniques: Injection, Isolation, Staining, Ex Vivo, Derivative Assay, Standard Deviation

    Amount and functionality of CD8 T cells in the livers and spleens of vaccinated HBV1.3tg mice with and without CD70 co-expression. HBV1.3tg mice were immunized with protein-prime (day 0, HBc + CpG + PCEP, group wt only CpG and PCEP) and MVA boost (day 21, with MVAwt (group wt), rMVA-HBc (group HBc) or rMVA-HBc-CD70 (group HBc-CD70)). Mice were divided into groups with low to moderate HBeAg levels (1–8 S/CO, “low viremia”) and high antigen levels (8–23 S/CO, “high viremia”) before the experiment. At day 35, splenocytes and liver-associated lymphocytes of mice were isolated. ( A ) Representative dot blot analysis of liver-associated lymphocytes (LAL) for single mice of each vaccination group, utilizing C 93 multimer staining. ( B ) Representative dot blot analysis of intracellular cytokine staining (IFNγ) after ex vivo C 93 stimulation of LALs. ( C ) Percentages of C 93 multimer-positive CD8 T cells in vaccinated mice. ( D ) HBV core-specific CD8 T cell response for the groups of mice with low and high viremia represented by the portion of CD8 T cells expressing IFNγ after ex vivo stimulation with C 93 peptide. ( E ) MVA-specific CD8 T cell response represented by the portion of CD8 T cells expressing IFNγ after ex vivo stimulation with B8R peptide. Mice with low and high viremia are presented together. C 93 : HBV core-derived CD8 T cell epitope; B8R: MVA-derived CD8 T cell epitope; Crosses and triangles represent individual mice; Horizontal lines indicate mean values; Error bars indicate standard deviation. Differences between groups HBc and HBc-CD70 (if >2 mice/group) were not statistically significant (one-way ANOVA and unpaired t-test).

    Journal: Vaccines

    Article Title: Evaluation of the Effect of CD70 Co-Expression on CD8 T Cell Response in Protein-Prime MVA-Boost Vaccination in Mice

    doi: 10.3390/vaccines11020245

    Figure Lengend Snippet: Amount and functionality of CD8 T cells in the livers and spleens of vaccinated HBV1.3tg mice with and without CD70 co-expression. HBV1.3tg mice were immunized with protein-prime (day 0, HBc + CpG + PCEP, group wt only CpG and PCEP) and MVA boost (day 21, with MVAwt (group wt), rMVA-HBc (group HBc) or rMVA-HBc-CD70 (group HBc-CD70)). Mice were divided into groups with low to moderate HBeAg levels (1–8 S/CO, “low viremia”) and high antigen levels (8–23 S/CO, “high viremia”) before the experiment. At day 35, splenocytes and liver-associated lymphocytes of mice were isolated. ( A ) Representative dot blot analysis of liver-associated lymphocytes (LAL) for single mice of each vaccination group, utilizing C 93 multimer staining. ( B ) Representative dot blot analysis of intracellular cytokine staining (IFNγ) after ex vivo C 93 stimulation of LALs. ( C ) Percentages of C 93 multimer-positive CD8 T cells in vaccinated mice. ( D ) HBV core-specific CD8 T cell response for the groups of mice with low and high viremia represented by the portion of CD8 T cells expressing IFNγ after ex vivo stimulation with C 93 peptide. ( E ) MVA-specific CD8 T cell response represented by the portion of CD8 T cells expressing IFNγ after ex vivo stimulation with B8R peptide. Mice with low and high viremia are presented together. C 93 : HBV core-derived CD8 T cell epitope; B8R: MVA-derived CD8 T cell epitope; Crosses and triangles represent individual mice; Horizontal lines indicate mean values; Error bars indicate standard deviation. Differences between groups HBc and HBc-CD70 (if >2 mice/group) were not statistically significant (one-way ANOVA and unpaired t-test).

    Article Snippet: Surface markers were stained with PB-conjugated anti-CD8 T cell antibody (clone 56.6-7, BD Biosciences, Heidelberg, Germany) and anti-CD4-PE (eBioscience, San Diego, USA).

    Techniques: Expressing, Isolation, Dot Blot, Staining, Ex Vivo, Derivative Assay, Standard Deviation

    Interleukin (IL)-7 promotes expansion of splenic T and B cells . Total number of thymocytes was not affected by IL-7. The absolute numbers of CD4CD8 double negative (DN), CD4CD8 double positive (DP), and single-positive CD4 and CD8 thymocytes were not changed by treatment with IL-7 (A) . Peripheral cell numbers, measured by total numbers of splenocytes, CD4 + T cells, CD8 + T cells, CD19 + B cells, and germinal center (GL7 + ) B cells were all increased by IL-7 compared with PBS treatment (B) . Values are expressed as mean ± SEM of 15 mice per group. Statistical differences with PBS group of * P < 0.05 or ** P < 0.005.

    Journal: Arthritis Research & Therapy

    Article Title: Interleukin-7-aggravated joint inflammation and tissue destruction in collagen-induced arthritis is associated with T-cell and B-cell activation

    doi: 10.1186/ar3870

    Figure Lengend Snippet: Interleukin (IL)-7 promotes expansion of splenic T and B cells . Total number of thymocytes was not affected by IL-7. The absolute numbers of CD4CD8 double negative (DN), CD4CD8 double positive (DP), and single-positive CD4 and CD8 thymocytes were not changed by treatment with IL-7 (A) . Peripheral cell numbers, measured by total numbers of splenocytes, CD4 + T cells, CD8 + T cells, CD19 + B cells, and germinal center (GL7 + ) B cells were all increased by IL-7 compared with PBS treatment (B) . Values are expressed as mean ± SEM of 15 mice per group. Statistical differences with PBS group of * P < 0.05 or ** P < 0.005.

    Article Snippet: For flow-cytometric analysis, monoclonal antibodies were used: anti-CD4 allophycocyanin (APC)/Cy7 (clone-Gk1.5; BD), anti-CD8 Pacific Blue (PB) (clone-53-6.7; BD), anti-CD19 peridinin-chlorophyll-protein (PerCP)/Cy5.5 (clone-1D3; BD), anti-CD44 FITC (clone-IM7; eBioscience, San Diego, CA, USA), and anti-CD62L APC (clone-mel-14; BD).

    Techniques:

    A) C57BL/6 mice were randomized to control vs. cancer groups. The cancer group received a subcutaneous injection of Pan02 cells. Following 3 weeks, all mice were given an IV injection of transgenic (Tg) T cell receptor (TCR) CD8 + Thy1.1 + T cells. After 24 hours, uninfected mice were sacrificed for the day 0 time point, and all other mice were given an intraperitoneal injection of LM-OVA and underwent spleen collections at days 5 and 14 post-infection. B) At days 5 or 14 following infection, there were no significant differences in antigen-specific CD8+T cells expansion between the control and cancer groups. The mean frequencies in control vs. cancer were 6.97±1.49% vs. 6.89±2.49% at day 5, respectively and 5.38±0.73% vs. 4.90±1.19% at day 14, respectively; n = 8–10 at all time points.

    Journal: PLoS ONE

    Article Title: Phenotypic T Cell Exhaustion in a Murine Model of Bacterial Infection in the Setting of Pre-Existing Malignancy

    doi: 10.1371/journal.pone.0093523

    Figure Lengend Snippet: A) C57BL/6 mice were randomized to control vs. cancer groups. The cancer group received a subcutaneous injection of Pan02 cells. Following 3 weeks, all mice were given an IV injection of transgenic (Tg) T cell receptor (TCR) CD8 + Thy1.1 + T cells. After 24 hours, uninfected mice were sacrificed for the day 0 time point, and all other mice were given an intraperitoneal injection of LM-OVA and underwent spleen collections at days 5 and 14 post-infection. B) At days 5 or 14 following infection, there were no significant differences in antigen-specific CD8+T cells expansion between the control and cancer groups. The mean frequencies in control vs. cancer were 6.97±1.49% vs. 6.89±2.49% at day 5, respectively and 5.38±0.73% vs. 4.90±1.19% at day 14, respectively; n = 8–10 at all time points.

    Article Snippet: Cells were stained with anti-CD4-PO (Invitrogen), anti-CD44-FITC and anti-Thy1.1-PerCP (all from BD Pharmingen), anti-CD8-PB, anti-PD-1-FITC, anti-BTLA-PE, and anti-2B4-allophycocyanin (all from eBioscience).

    Techniques: Injection, IV Injection, Transgenic Assay, Infection

    No differences were noted in the mean frequency of the activated CD8 + Thy1.1 + T cell response at day 5 (98.89±0.14 vs. 98.81±0.19) and 14 (98.18 ±0.21 vs. 98.32±0.35) in the control vs. cancer groups, respectively. Similarly, activated CD4 + T cell frequencies were not different at day 5 (27.37±0.77 vs. 29.67±1.95) or day 14 (25.50±0.84 vs. 24.84±0.85). Also, the frequency of CD8 + T cell activation was not different at days 5 (48.97±3.12 vs. 49.18±4.90) and 14 (42.62±2.98 vs. 43.01±3.44) in control vs. cancer, respectively; p = ns and n = 8–10.

    Journal: PLoS ONE

    Article Title: Phenotypic T Cell Exhaustion in a Murine Model of Bacterial Infection in the Setting of Pre-Existing Malignancy

    doi: 10.1371/journal.pone.0093523

    Figure Lengend Snippet: No differences were noted in the mean frequency of the activated CD8 + Thy1.1 + T cell response at day 5 (98.89±0.14 vs. 98.81±0.19) and 14 (98.18 ±0.21 vs. 98.32±0.35) in the control vs. cancer groups, respectively. Similarly, activated CD4 + T cell frequencies were not different at day 5 (27.37±0.77 vs. 29.67±1.95) or day 14 (25.50±0.84 vs. 24.84±0.85). Also, the frequency of CD8 + T cell activation was not different at days 5 (48.97±3.12 vs. 49.18±4.90) and 14 (42.62±2.98 vs. 43.01±3.44) in control vs. cancer, respectively; p = ns and n = 8–10.

    Article Snippet: Cells were stained with anti-CD4-PO (Invitrogen), anti-CD44-FITC and anti-Thy1.1-PerCP (all from BD Pharmingen), anti-CD8-PB, anti-PD-1-FITC, anti-BTLA-PE, and anti-2B4-allophycocyanin (all from eBioscience).

    Techniques: Activation Assay

    A) Data presented is following selection of the CD8 + Thy1.1 + T cell population. CD8 + Thy1.1 + T cells in cancer group had increased mean frequencies of BTLA + T cells. They were 8.58±1.07% in control vs. 20.72±5.58% in cancer mice following infection (*p<0.05; n = 8–10) at day 5. Mean frequencies of 2B4 (n = 4–5) and PD-1 (n = 8–10) had a trend toward increased expression in the cancer group, but were not statistically significant. B) In the absence of infection (day 0), the control and cancer groups did not have any significant differences in the expression or co-expression of 2B4, BTLA, and PD-1 on CD4 + T cells. At day 5, however, CD4 + T cells in the cancer group expressed a higher frequency of BTLA (4.03±0.46 vs. 6.77±0.59) and 2B4 (2.67±0.22 vs. 3.95±0.25). The inhibitory profile was further altered when looking at co-expression. The cancer group had higher expression of PD-1 + BTLA + (3.76±0.47 vs. 5.65±0.42) and 2B4 + PD-1 + (2.50±0.23 vs. 3.76±0.26) CD4 + T cells. Following resolution of infection at day 14, the expression of 2B4 (n = 4–5), 2B4 + PD-1 + (n = 4–5), or PD-1 was no longer different in both groups, however, the frequency of expression CD4 + PD-1 + BTLA + T cells remained elevated in the cancer group (3.99±0.44 vs. 5.56±0.48). **p<0.01; *p<0.05; n = 8–10 at days 0, 5, and 14, unless otherwise stated. C) At baseline (day 0), cancer mice had reduced expression of CD8 + PD-1 + T cells compared to control mice (14.03±0.61 in control vs. 11.91±0.47 in cancer). However, expression of 2B4, BTLA, 2B4 + PD-1 + or PD-1 + BTLA + was unchanged prior to infection. At day 5 following infection, cancer mice had increased frequencies of expression of CD8 + BTLA + (8.78±0.95 vs. 13.66±0.64) and CD8 + PD-1 + BTLA + (6.55±0.83 vs. 9.22±0.47) T cells. Following resolution of infection at day 14, only the mean frequency of BTLA expression in the cancer group remained elevated (6.72±1.40 vs. 8.76±2.03); **p<0.01; *p<0.05; n = 8–10.

    Journal: PLoS ONE

    Article Title: Phenotypic T Cell Exhaustion in a Murine Model of Bacterial Infection in the Setting of Pre-Existing Malignancy

    doi: 10.1371/journal.pone.0093523

    Figure Lengend Snippet: A) Data presented is following selection of the CD8 + Thy1.1 + T cell population. CD8 + Thy1.1 + T cells in cancer group had increased mean frequencies of BTLA + T cells. They were 8.58±1.07% in control vs. 20.72±5.58% in cancer mice following infection (*p<0.05; n = 8–10) at day 5. Mean frequencies of 2B4 (n = 4–5) and PD-1 (n = 8–10) had a trend toward increased expression in the cancer group, but were not statistically significant. B) In the absence of infection (day 0), the control and cancer groups did not have any significant differences in the expression or co-expression of 2B4, BTLA, and PD-1 on CD4 + T cells. At day 5, however, CD4 + T cells in the cancer group expressed a higher frequency of BTLA (4.03±0.46 vs. 6.77±0.59) and 2B4 (2.67±0.22 vs. 3.95±0.25). The inhibitory profile was further altered when looking at co-expression. The cancer group had higher expression of PD-1 + BTLA + (3.76±0.47 vs. 5.65±0.42) and 2B4 + PD-1 + (2.50±0.23 vs. 3.76±0.26) CD4 + T cells. Following resolution of infection at day 14, the expression of 2B4 (n = 4–5), 2B4 + PD-1 + (n = 4–5), or PD-1 was no longer different in both groups, however, the frequency of expression CD4 + PD-1 + BTLA + T cells remained elevated in the cancer group (3.99±0.44 vs. 5.56±0.48). **p<0.01; *p<0.05; n = 8–10 at days 0, 5, and 14, unless otherwise stated. C) At baseline (day 0), cancer mice had reduced expression of CD8 + PD-1 + T cells compared to control mice (14.03±0.61 in control vs. 11.91±0.47 in cancer). However, expression of 2B4, BTLA, 2B4 + PD-1 + or PD-1 + BTLA + was unchanged prior to infection. At day 5 following infection, cancer mice had increased frequencies of expression of CD8 + BTLA + (8.78±0.95 vs. 13.66±0.64) and CD8 + PD-1 + BTLA + (6.55±0.83 vs. 9.22±0.47) T cells. Following resolution of infection at day 14, only the mean frequency of BTLA expression in the cancer group remained elevated (6.72±1.40 vs. 8.76±2.03); **p<0.01; *p<0.05; n = 8–10.

    Article Snippet: Cells were stained with anti-CD4-PO (Invitrogen), anti-CD44-FITC and anti-Thy1.1-PerCP (all from BD Pharmingen), anti-CD8-PB, anti-PD-1-FITC, anti-BTLA-PE, and anti-2B4-allophycocyanin (all from eBioscience).

    Techniques: Selection, Infection, Expressing

    CD8 + Thy1.1 + T cells in the control and cancer groups were stimulated with SIINFEKL peptide. No statistically significant differences were noted in intracellular production of IFN-γ or IL-2; n = 8–10.

    Journal: PLoS ONE

    Article Title: Phenotypic T Cell Exhaustion in a Murine Model of Bacterial Infection in the Setting of Pre-Existing Malignancy

    doi: 10.1371/journal.pone.0093523

    Figure Lengend Snippet: CD8 + Thy1.1 + T cells in the control and cancer groups were stimulated with SIINFEKL peptide. No statistically significant differences were noted in intracellular production of IFN-γ or IL-2; n = 8–10.

    Article Snippet: Cells were stained with anti-CD4-PO (Invitrogen), anti-CD44-FITC and anti-Thy1.1-PerCP (all from BD Pharmingen), anti-CD8-PB, anti-PD-1-FITC, anti-BTLA-PE, and anti-2B4-allophycocyanin (all from eBioscience).

    Techniques:

    In silico and in vitro peptide analyses. a , b Venn diagrams of the number of a core peptide sequences that showed weak binding ( a ) and strong binding ( b ) to HLA-DRB1*12:01 and HLA-DRB1*12:02. The data were obtained from NetMHCIIpan version 4.0. c In silico analysis for seven common core peptides obtained from ( b ). The predicted B cell epitope amino acid positions were obtained by a BepiPred Linear Epitope Prediction 2.0. NA, not applicable; ND, not detected. d Schematic diagram of domain structures of SARS-CoV-2 Spike protein. NTD, N-terminal domain; RBD, receptor-binding domain; RBM, receptor-binding motif, SD, subdomain; S2′, S2′ protease cleavage site; FP, fusion peptide; HR, heptad repeat; CH, central helix; CD, connector domain; TM, transmembrane domain; CT, cytoplasmic tail. Numbers indicate the positions of the amino acid sequence. Triangles indicate the locations of common core peptides, the colors of which are black (strong binding to HLA-DR12, predicted B cell epitope, shared sequence with RBC membrane protein), gray (strong binding to HLA-DR12 and predicted B cell epitope), or white (strong binding to HLA-DR12 but not a predicted B cell epitope). e , f Flow cytometric analysis showing the expression of HLA-DR on CD4 + T cells ( e ) and CD8 + T cells ( f ) that were pulsed with or without a TSNFR-containing peptide at the indicated concentrations

    Journal: Annals of Hematology

    Article Title: An association between a positive direct antiglobulin test and HLA-DR12 in COVID-19

    doi: 10.1007/s00277-022-04921-9

    Figure Lengend Snippet: In silico and in vitro peptide analyses. a , b Venn diagrams of the number of a core peptide sequences that showed weak binding ( a ) and strong binding ( b ) to HLA-DRB1*12:01 and HLA-DRB1*12:02. The data were obtained from NetMHCIIpan version 4.0. c In silico analysis for seven common core peptides obtained from ( b ). The predicted B cell epitope amino acid positions were obtained by a BepiPred Linear Epitope Prediction 2.0. NA, not applicable; ND, not detected. d Schematic diagram of domain structures of SARS-CoV-2 Spike protein. NTD, N-terminal domain; RBD, receptor-binding domain; RBM, receptor-binding motif, SD, subdomain; S2′, S2′ protease cleavage site; FP, fusion peptide; HR, heptad repeat; CH, central helix; CD, connector domain; TM, transmembrane domain; CT, cytoplasmic tail. Numbers indicate the positions of the amino acid sequence. Triangles indicate the locations of common core peptides, the colors of which are black (strong binding to HLA-DR12, predicted B cell epitope, shared sequence with RBC membrane protein), gray (strong binding to HLA-DR12 and predicted B cell epitope), or white (strong binding to HLA-DR12 but not a predicted B cell epitope). e , f Flow cytometric analysis showing the expression of HLA-DR on CD4 + T cells ( e ) and CD8 + T cells ( f ) that were pulsed with or without a TSNFR-containing peptide at the indicated concentrations

    Article Snippet: Then, the cells were stained for 20 min at 4°C with APC-conjugated mouse anti-human CD3 (BD Pharmingen, Franklin Lakes, NJ, clone UCHT1), Pacific orange (PO)-conjugated mouse anti-human CD4 (Invitrogen/Thermo Fisher Scientific, clone RPA-T4), Pacific Blue (PB)-conjugated mouse anti-human CD8 (BD Horizon, Franklin Lakes, NJ, clone PRA-T8), and PE-conjugated mouse anti-human HLA-DR (Invitrogen/Thermo Fisher Scientific, clone L243).

    Techniques: In Silico, In Vitro, Binding Assay, Sequencing, Expressing